BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2788541)

  • 1. Elimination of soluble 123I-labelled aggregates of human immunoglobulin G in humans; the effect of splenectomy.
    Halma C; Daha MR; van Furth R; Camps JA; Evers-Schouten JH; Pauwels EK; Lobatto S; Van Es LA
    Clin Exp Immunol; 1989 Jul; 77(1):62-6. PubMed ID: 2788541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal clearance of soluble aggregates of human immunoglobulin G in patients with systemic lupus erythematosus.
    Lobatto S; Daha MR; Breedveld FC; Pauwels EK; Evers-Schouten JH; Voetman AA; Cats A; Van Es LA
    Clin Exp Immunol; 1988 Apr; 72(1):55-9. PubMed ID: 3396221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearance of soluble aggregates of human immunoglobulin G in healthy volunteers and chimpanzees.
    Lobatto S; Daha MR; Voetman AA; Evers-Schouten JH; Van Es AA; Pauwels EK; Van Es LA
    Clin Exp Immunol; 1987 Jul; 69(1):133-41. PubMed ID: 3652528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of monomeric immunoglobulin G (IgG) on the clearance of soluble aggregates of IgG in man.
    Halma C; Daha MR; van der Meer JW; Cohen A; van Furth R; Breedveld FC; Evers-Schouten JH; Pauwels EK; van Es LA
    J Clin Lab Immunol; 1991 May; 35(1):9-15. PubMed ID: 1668290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding and catabolism of aggregated immunoglobulins bearing C3b or iC3b by U937 cells.
    Daha MR; Gorter A; Leijh PJ; Klar N; van Es LA
    Immunology; 1988 Jul; 64(3):375-9. PubMed ID: 2970428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of complement component C3 is associated with accelerated removal of soluble 123I-labelled aggregates of IgG from the circulation.
    Halma C; Daha MR; Camps JA; Evers-Schouten JH; Pauwels EK; Van Es
    Clin Exp Immunol; 1992 Dec; 90(3):394-400. PubMed ID: 1458675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished uptake and degradation of soluble aggregates of IgG by monocytes of patients with rheumatoid arthritis and vasculitis.
    Daha MR; Westedt ML; Bos B; Krol MC; van Es LA; Cats A
    J Rheumatol; 1987 Aug; 14(4):680-5. PubMed ID: 3668974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement enhances the elimination of soluble aggregates of IgG by rat liver endothelial cells in vivo.
    Bogers WM; van Rooijen N; Janssen DJ; van Es LA; Daha MR
    Eur J Immunol; 1993 Feb; 23(2):433-8. PubMed ID: 8436178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement-dependent inhibition of degradation of soluble immune complexes and immunoglobulin aggregates by thioglycollate-stimulated peritoneal macrophages.
    Daha MR; Van Es LA
    Immunology; 1983 Sep; 50(1):107-11. PubMed ID: 6224740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished clearance of soluble aggregates of human immunoglobulin G in patients with rheumatoid arthritis.
    Lobatto S; Daha MR; Westedt ML; Pauwels EK; Evers-Schouten JH; Voetman AA; Cats A; van Es LA
    Scand J Rheumatol; 1989; 18(2):89-96. PubMed ID: 2734596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cellular Fc and C3 receptors on the complement-dependent degradation of stable soluble immunoglobulin aggregates by normal and trypsin-treated peritoneal macrophages.
    Daha MR; van Es LA
    Immunology; 1982 Sep; 47(1):203-9. PubMed ID: 7118161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in clearance kinetics of particulate immune complexes and soluble aggregates of IgG in vivo.
    Veerhuis R; Krol MC; van Es LA; Daha MR
    Clin Immunol Immunopathol; 1986 Dec; 41(3):379-91. PubMed ID: 3780052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous immune complex nephritis in rats. Influence of modification of mononuclear phagocyte system function.
    Abrass CK
    Lab Invest; 1984 Aug; 51(2):162-71. PubMed ID: 6611451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of soluble immunoglobulin aggregates in vitro by monocytes from normal subjects and from patients with systemic lupus erythematosus.
    Daha MR; van ES LA; Hazevoet HM; Kijlstra A
    Scand J Immunol; 1982 Aug; 16(2):117-22. PubMed ID: 7134889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective splenic reticuloendothelial function in idiopathic membranous nephropathy.
    McGinley E; Martin W; Henderson N; Boulton-Jones JM
    Clin Exp Immunol; 1984 May; 56(2):295-301. PubMed ID: 6587955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo degradation of rat C1q induced by intravenous injection of soluble IgG aggregates.
    Veerhuis R; van Es LA; Daha MR
    Immunology; 1985 Apr; 54(4):801-10. PubMed ID: 3872261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of soluble 123I-labeled aggregates of IgG in patients with systemic lupus erythematosus. Effect of serum IgG and numbers of erythrocyte complement receptor type 1.
    Halma C; Breedveld FC; Daha MR; Blok D; Evers-Schouten JH; Hermans J; Pauwels EK; van Es LA
    Arthritis Rheum; 1991 Apr; 34(4):442-52. PubMed ID: 1826424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver cell uptake and degradation of soluble immunoglobulin G immune complexes in vivo and in vitro in rats.
    Johansson AG; Løvdal T; Magnusson KE; Berg T; Skogh T
    Hepatology; 1996 Jul; 24(1):169-75. PubMed ID: 8707258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenic uptake of immune complexes in man is complement-dependent.
    Davies KA; Erlendsson K; Beynon HL; Peters AM; Steinsson K; Valdimarsson H; Walport MJ
    J Immunol; 1993 Oct; 151(7):3866-73. PubMed ID: 8376807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced alternative complement pathway-dependent degradation of soluble immunoglobulin aggregates by macrophages.
    Daha MR; Van Es LA
    Immunology; 1981 Jul; 43(3):513-8. PubMed ID: 7251062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.